title: 5,6-Dimethoxybenzofuran-3-one derivatives: a novel series of dual Acetylcholinesterase/Butyrylcholinesterase inhibitors bearing benzyl pyridinium moiety.
abstract: BACKGROUND
  Several studies have been focused on design and synthesis of multi-target anti Alzheimer compounds. Utilizing of the dual Acetylcholinesterase/Butyrylcholinesterase inhibitors has gained more interest to treat the Alzheimer's disease. As a part of a research program to find a novel drug for treating Alzheimer disease, we have previously reported 6-alkoxybenzofuranone derivatives as potent acetylcholinesterase inhibitors. In continuation of our work, we would like to report the synthesis of 5,6-dimethoxy benzofuranone derivatives bearing a benzyl pyridinium moiety as dual Acetylcholinesterase/Butyrylcholinesterase inhibitors.
  
  
  METHODS
  The synthesis of target compounds was carried out using a conventional method. Bayer-Villiger oxidation of 3,4-dimethoxybenzaldehyde furnished 3,4-dimethoxyphenol. The reaction of 3,4-dimethoxyphenol with chloroacetonitrile followed by treatment with HCl solution and then ring closure yielded the 5,6-dimethoxy benzofuranone. Condensation of the later compound with pyridine-4-carboxaldehyde and subsequent reaction with different benzyl halides afforded target compounds. The biological activity was measured using standard Ellman's method. Docking studies were performed to get better insight into interaction of compounds with receptor.
  
  
  RESULTS
  The in vitro anti acetylcholinesterase/butyrylcholinesterase activity of compounds revealed that, all of the target compounds have good inhibitory activity against both Acetylcholinesterase/Butyrylcholinesterase enzymes in which compound 5b (IC50 = 52 ± 6.38nM) was the most active compound against acetylcholinesterase. The same binding mode and interactions were observed for the reference drug donepezil and compound 5b in docking study.
  
  
  CONCLUSIONS
  In this study, we presented a new series of benzofuranone-based derivatives having pyridinium moiety as potent dual acting Acetylcholinesterase/Butyrylcholinesterase inhibitors.
authors: Neuroscience Research Center, Kerman University of Medical Sciences, Kerman, Iran. aforoumadi@yahoo.com.
authors: Hamid
authors: H
authors: Nadri
authors: Morteza
authors: M
authors: Pirali-Hamedani
authors: Alireza
authors: A
authors: Moradi
authors: Amirhossein
authors: A
authors: Sakhteman
authors: Alireza
authors: A
authors: Vahidi
authors: Vahid
authors: V
authors: Sheibani
authors: Ali
authors: A
authors: Asadipour
authors: Nouraddin
authors: N
authors: Hosseinzadeh
authors: Mohammad
authors: M
authors: Abdollahi
authors: Abbas
authors: A
authors: Shafiee
authors: Alireza
authors: A
authors: Foroumadi